Optimalisation of fluid balance with FlowTrac/Vigileo during the HIPEC procedure

Completed

• Conditions: colon and ovarium cancer; intraperitoneal metastasis; 10017990

• Registration Number: NL-OMON35708
• Lead Sponsor: Sint Antonius Ziekenhuis

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 40

Inclusion Criteria

patients 18 years and older who require HIPEC procedures

Exclusion Criteria

LVEF <40%
preoperative arrythmia
severe coronary artery disease
no epidural analgesia
termination of HIPEC procedure
use of preoperative diuretics.

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The primary endpoint is a 30% reduction in the amount of fluid administered<br /><br>during the first 24 hours.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secondary endpoints are differences in the number and type of postoperative<br /><br>complications, ventilation and ICU and hospital length of stay, inflammatory<br /><br>response measured by CRP and interleukin values.</p><br>